Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

Journal of the American College of Cardiology

Volumn 55, Issue 13, 2010, Pages 1362-1369

  Gränsbo, Klas ^a   Melander, Olle ^a   Wallentin, Lars ^b   Lindbäck, Johan ^b   Stenestrand, Ulf ^c   Carlsson, Jörg ^d   Nilsson, Jan ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

elderly; myocardial infarction; statins

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL; COMORBIDITY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT;

AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; SWEDEN;

EID: 77949565021     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.013     Document Type: Article

References (22)

1. American Heart Association. Heart disease and stroke statistics update-2008. Circulation 117 (2008) e25-e146
2. Ali O., Sadiq I., Goldberg R.J., et al. Age-specific differences in the use of thrombolytic therapy and hospital outcomes in patients with acute myocardial infarction: a community-wide perspective. J Thromb Thrombolysis 14 (2002) 5-14
3. Halon D.A., Adawi S., Dobrecky-Mery I., and Lewis B.S. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. J Am Coll Cardiol 43 (2004) 346-352
4. Tran C.T., Laupacis A., Mamdani M.M., and Tu J.V. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Am Heart J 148 (2004) 834-841
5. Wong C.K., Newby L.K., Bhapker M.V., et al. Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials. Am Heart J 154 (2007) 313-321
6. Nichols G.A., Nag S., and Chan W. Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update. Am Heart J 154 (2007) 554-560
7. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
8. Avezum A., Makdisse M., Spencer F., et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149 (2005) 67-73
9. Rosengren A., Wallentin L., Simoons M., et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 27 (2006) 789-795
10. Weverling-Rijnsburger A.W., Blauw G.J., Lagaay A.M., Knook D.L., Meinders A.E., and Westendorp R.G. Total cholesterol and risk of mortality in the oldest old. Lancet 350 (1997) 1119-1123
11. Schatz I.J., Masaki K., Yano K., Chen R., Rodriguez B.L., and Curb J.D. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 358 (2001) 351-355
12. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
13. Stenestrand U., and Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 285 (2001) 430-436
14. Bauer T., Bohm M., Zahn R., et al. Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction. J Cardiovasc Pharmacol 53 (2009) 132-136
15. Lev E.I., Kornowski R., Vaknin-Assa H., et al. Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 103 (2009) 165-169
16. Strandberg T.E., Pyorala K., Cook T.J., et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 364 (2004) 771-777
17. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
18. Bjerre L.M., and LeLorier J. Do statins cause cancer?. A meta-analysis of large randomized clinical trials. Am J Med 110 (2001) 716-723
19. Dale K.M., Coleman C.I., Henyan N.N., Kluger J., and White C.M. Statins and cancer risk: a meta-analysis. JAMA 295 (2006) 74-80
20. Alsheikh-Ali A.A., Trikalinos T.A., Kent D.M., and Karas R.H. Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol 52 (2008) 1141-1147
21. Chodick G., Shalev V., Gerber Y., et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin Ther 30 (2008) 2167-2179
22. Perreault S., Dragomir A., Blais L., et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol 65 (2009) 1013-1024